AGFA-GEVAERT NV (AGFB.BR) Stock Fundamental Analysis

EBR:AGFB • BE0003755692

0.491 EUR
-0.01 (-1.01%)
Last: Feb 25, 2026, 12:42 PM
Fundamental Rating

3

AGFB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. While AGFB seems to be doing ok healthwise, there are quite some concerns on its profitability. AGFB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • AGFB had negative earnings in the past year.
  • In the past year AGFB had a positive cash flow from operations.
  • In the past 5 years AGFB reported 4 times negative net income.
  • AGFB had a negative operating cash flow in each of the past 5 years.
AGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFAGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

  • The Return On Assets of AGFB (-5.65%) is worse than 63.64% of its industry peers.
  • AGFB's Return On Equity of -25.44% is on the low side compared to the rest of the industry. AGFB is outperformed by 63.64% of its industry peers.
Industry RankSector Rank
ROA -5.65%
ROE -25.44%
ROIC N/A
ROA(3y)-8.91%
ROA(5y)0.06%
ROE(3y)-32.3%
ROE(5y)1.63%
ROIC(3y)N/A
ROIC(5y)N/A
AGFB.BR Yearly ROA, ROE, ROICAGFB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • In the last couple of years the Operating Margin of AGFB has declined.
  • AGFB has a worse Gross Margin (29.77%) than 72.73% of its industry peers.
  • AGFB's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AGFB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.77%
OM growth 3Y-1.64%
OM growth 5Y-16.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.88%
AGFB.BR Yearly Profit, Operating, Gross MarginsAGFB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

5

2. Health

2.1 Basic Checks

  • AGFB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AGFB remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for AGFB has been reduced compared to 5 years ago.
  • AGFB has a worse debt/assets ratio than last year.
AGFB.BR Yearly Shares OutstandingAGFB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AGFB.BR Yearly Total Debt VS Total AssetsAGFB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.30 indicates that AGFB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AGFB's Altman-Z score of 2.30 is fine compared to the rest of the industry. AGFB outperforms 63.64% of its industry peers.
  • AGFB has a debt to FCF ratio of 8.85. This is a slightly negative value and a sign of low solvency as AGFB would need 8.85 years to pay back of all of its debts.
  • AGFB has a Debt to FCF ratio (8.85) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.57 indicates that AGFB is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.57, AGFB is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.85
Altman-Z 2.3
ROIC/WACCN/A
WACC11.97%
AGFB.BR Yearly LT Debt VS Equity VS FCFAGFB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • AGFB has a Current Ratio of 2.02. This indicates that AGFB is financially healthy and has no problem in meeting its short term obligations.
  • AGFB has a better Current ratio (2.02) than 72.73% of its industry peers.
  • AGFB has a Quick Ratio of 1.17. This is a normal value and indicates that AGFB is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.17, AGFB perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.17
AGFB.BR Yearly Current Assets VS Current LiabilitesAGFB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

3

3. Growth

3.1 Past

  • The earnings per share for AGFB have decreased strongly by -111.68% in the last year.
  • The Revenue has decreased by -1.87% in the past year.
  • Measured over the past years, AGFB shows a very negative growth in Revenue. The Revenue has been decreasing by -10.44% on average per year.
EPS 1Y (TTM)-111.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.44%
Sales Q2Q%-7.22%

3.2 Future

  • AGFB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.19% yearly.
  • AGFB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.57% yearly.
EPS Next Y14.29%
EPS Next 2Y57.36%
EPS Next 3Y47.94%
EPS Next 5Y32.19%
Revenue Next Year-3.86%
Revenue Next 2Y-1.69%
Revenue Next 3Y-0.43%
Revenue Next 5Y0.57%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGFB.BR Yearly Revenue VS EstimatesAGFB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AGFB.BR Yearly EPS VS EstimatesAGFB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

6

4. Valuation

4.1 Price/Earnings Ratio

  • AGFB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 9.63, the valuation of AGFB can be described as reasonable.
  • 90.91% of the companies in the same industry are more expensive than AGFB, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of AGFB to the average of the S&P500 Index (28.01), we can say AGFB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.63
AGFB.BR Price Earnings VS Forward Price EarningsAGFB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AGFB is valued a bit more expensive than 63.64% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AGFB indicates a rather cheap valuation: AGFB is cheaper than 90.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.8
EV/EBITDA 62.93
AGFB.BR Per share dataAGFB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AGFB's earnings are expected to grow with 47.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.36%
EPS Next 3Y47.94%

0

5. Dividend

5.1 Amount

  • AGFB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AGFA-GEVAERT NV

EBR:AGFB (2/25/2026, 12:42:24 PM)

0.491

-0.01 (-1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-13
Earnings (Next)03-11
Inst Owners49.3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap76.02M
Revenue(TTM)1.10B
Net Income(TTM)-73.00M
Analysts43.64
Price Target0.88 (79.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.36%
Min Revenue beat(2)-7.11%
Max Revenue beat(2)-1.61%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-1000%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.63
P/S 0.07
P/FCF 3.8
P/OCF 1.36
P/B 0.26
P/tB 1.41
EV/EBITDA 62.93
EPS(TTM)-0.46
EYN/A
EPS(NY)0.05
Fwd EY10.39%
FCF(TTM)0.13
FCFY26.31%
OCF(TTM)0.36
OCFY73.67%
SpS7.14
BVpS1.85
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.65%
ROE -25.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.77%
FCFM 1.81%
ROA(3y)-8.91%
ROA(5y)0.06%
ROE(3y)-32.3%
ROE(5y)1.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.64%
OM growth 5Y-16.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.88%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.85
Debt/EBITDA 54.33
Cap/Depr 100%
Cap/Sales 3.26%
Interest Coverage N/A
Cash Conversion 1866.67%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.17
Altman-Z 2.3
F-Score3
WACC11.97%
ROIC/WACCN/A
Cap/Depr(3y)78.36%
Cap/Depr(5y)64.97%
Cap/Sales(3y)3.26%
Cap/Sales(5y)2.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y14.29%
EPS Next 2Y57.36%
EPS Next 3Y47.94%
EPS Next 5Y32.19%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.44%
Sales Q2Q%-7.22%
Revenue Next Year-3.86%
Revenue Next 2Y-1.69%
Revenue Next 3Y-0.43%
Revenue Next 5Y0.57%
EBIT growth 1Y-925%
EBIT growth 3Y-14.94%
EBIT growth 5Y-25.35%
EBIT Next Year134.7%
EBIT Next 3Y50.19%
EBIT Next 5Y43.36%
FCF growth 1Y119.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.16%
OCF growth 3YN/A
OCF growth 5YN/A

AGFA-GEVAERT NV / AGFB.BR FAQ

Can you provide the ChartMill fundamental rating for AGFA-GEVAERT NV?

ChartMill assigns a fundamental rating of 3 / 10 to AGFB.BR.


What is the valuation status for AGFB stock?

ChartMill assigns a valuation rating of 6 / 10 to AGFA-GEVAERT NV (AGFB.BR). This can be considered as Fairly Valued.


How profitable is AGFA-GEVAERT NV (AGFB.BR) stock?

AGFA-GEVAERT NV (AGFB.BR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for AGFB stock?

The Earnings per Share (EPS) of AGFA-GEVAERT NV (AGFB.BR) is expected to grow by 14.29% in the next year.


Is the dividend of AGFA-GEVAERT NV sustainable?

The dividend rating of AGFA-GEVAERT NV (AGFB.BR) is 0 / 10 and the dividend payout ratio is 0%.